Globus Medical (GMED)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	102,984	91,513	40,675	66,627	122,873	157,904	204,337	201,215	190,170	155,211	154,991	141,946	149,191	187,042	184,047	121,665	102,285	94,857	88,948	147,948
Total assets	US$ in thousands	5,251,750	5,086,040	4,993,790	4,943,610	5,086,080	5,355,880	2,212,460	2,149,620	2,076,130	1,976,510	1,914,710	1,998,690	1,957,260	1,910,580	1,830,210	1,737,890	1,679,480	1,541,740	1,465,800	1,479,360
ROA		1.96%	1.80%	0.81%	1.35%	2.42%	2.95%	9.24%	9.36%	9.16%	7.85%	8.09%	7.10%	7.62%	9.79%	10.06%	7.00%	6.09%	6.15%	6.07%	10.00%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $102,984K ÷ $5,251,750K
= 1.96%

The return on assets (ROA) for Globus Medical has shown some fluctuations over the past few years. The ROA was around 6% to 10% from March 2020 to June 2022, indicating the company was generating a decent return on its assets during this period. There was a slight decrease to around 7% in the latter part of 2022, but still within a reasonable range.

However, from September 2023 to December 2024, there was a significant decline in the ROA, dropping to as low as 0.81% in June 2024. This indicates that the company's ability to generate profits from its assets decreased substantially during this period.

Overall, the ROA trend for Globus Medical shows a mix of positive and negative performance, with a notable decline in recent periods raising concerns about the company's asset utilization efficiency and profitability. Further analysis of the company's financial and operational performance would be necessary to understand the underlying reasons for these fluctuations and to assess the company's future prospects.